180 Wealth Advisors LLC Trims Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

180 Wealth Advisors LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 59.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,003 shares of the company's stock after selling 1,453 shares during the quarter. 180 Wealth Advisors LLC's holdings in HCA Healthcare were worth $347,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in HCA. Norges Bank purchased a new position in HCA Healthcare in the 4th quarter worth about $840,286,000. GAMMA Investing LLC lifted its position in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. Royal London Asset Management Ltd. raised its stake in HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after buying an additional 574,239 shares during the last quarter. Barclays PLC grew its holdings in shares of HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock worth $318,727,000 after acquiring an additional 489,916 shares during the period. Finally, Principal Financial Group Inc. grew its stake in shares of HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after purchasing an additional 476,756 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Trading Down 0.1%

NYSE HCA traded down $0.31 during trading hours on Thursday, hitting $381.35. 1,058,650 shares of the company were exchanged, compared to its average volume of 1,438,757. The stock has a market cap of $91.74 billion, a PE ratio of 17.36, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a 50-day moving average price of $353.80 and a 200 day moving average price of $331.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.36 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HCA. Royal Bank of Canada reduced their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Robert W. Baird reiterated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Guggenheim initiated coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $388.80.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.